Cooperatieve Gilde Healthcare IV U.A. 4
4 · Inari Medical, Inc. · Filed Dec 4, 2020
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2020-12-02$65.04/sh−21,569$1,402,848→ 7,420,110 total(indirect: See footnote) - Sale
Common Stock
2020-12-02$63.81/sh−3,839$244,967→ 7,495,296 total(indirect: See footnote) - Sale
Common Stock
2020-12-03$65.03/sh−1,620$105,349→ 7,418,490 total(indirect: See footnote) - Sale
Common Stock
2020-12-02$65.50/sh−4,102$268,681→ 7,441,679 total(indirect: See footnote) - Sale
Common Stock
2020-12-02$64.89/sh−49,515$3,213,028→ 7,445,781 total(indirect: See footnote) - Sale
Common Stock
2020-12-04$65.01/sh−14,482$941,475→ 7,404,008 total(indirect: See footnote)
Footnotes (7)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.30 to $64.285, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.30 to $65.285, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.305 to $66.25, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.21, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.165, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.24, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.